Vargatef

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Vargatef, covering 2023-09-06 to 2026-06-10. Get the full timeline:

Most recent: EMA Authorised: Vargatef (nintedanib) — Boehringer Ingelheim International GmbH